Multiple Sclerosis Webinar: Ocrelizumab Q&A with Dr. Tim Vollmer TheMSCenter 49:12 7 years ago 24 972 Скачать Далее
Multiple Sclerosis Webinar: Ocrelizumab Q&A with Dr. Enrique Alvarez TheMSCenter 50:03 7 years ago 2 455 Скачать Далее
Ocrelizumab, and Treating Primary Progressive Multiple Sclerosis HCPLive 2:35 7 years ago 1 012 Скачать Далее
Research in Multiple Sclerosis | Webinar American Brain Foundation 55:58 2 years ago 1 602 Скачать Далее
Ocrelizumab: What to Know About the First Agent Approved for Primary Progressive MS Cleveland Clinic 5:47 7 years ago 36 174 Скачать Далее
Multiple Sclerosis Webinar: Diet and Nutrition in MS TheMSCenter 1:13:52 7 years ago 1 268 Скачать Далее
Multiple Sclerosis Webinar: Addressing Secondary MS Cleveland Clinic Abu Dhabi 1:41:53 2 years ago 1 427 Скачать Далее
Role of Ocrelizumab in Europe for Multiple Sclerosis NeurologyLive 6:39 4 years ago 313 Скачать Далее
Ocrelizumab Provides Potential Answer to Difficult Treatment Questions HCPLive 5:46 8 years ago 3 760 Скачать Далее
Ocrelizumab in Primary Progressive Multiple Sclerosis (PPMS) MStranslate 20:37 7 years ago 2 957 Скачать Далее
Should ocrelizumab & cladribine be treated in the same way as alemtuzumab in terms of COVID-19 risk? Neurology Academy 58:22 4 years ago 1 357 Скачать Далее
Multiple Sclerosis Webinar: The Emerging and Evolving Field of Neuroimmunology TheMSCenter 57:38 6 years ago 1 658 Скачать Далее
Multiple Sclerosis Rituxan Rituximab #3, then Ocrelizumab Dave M 2:12 7 years ago 1 988 Скачать Далее
Results of ocrelizumab in treatment-naïve patients with early relapsing MS VJNeurology 5:20 1 year ago 491 Скачать Далее